4th Annual Medical Device Summit 2018

By: FDA, EX-FDA Officials, Industry Veterans, Regulators and Industry Experts
Coming soon.. Please contact customer care for new schedule

Key Attraction

We need the below information to serve you better

novel ideas for advancements in medical device technologies without compromising their safety and effectiveness. This summit brings together some of the renowned R&D experts and technology innovators to share information regarding opportunities, obstacles, best practices and challenges in the development of the new devices. Attendees will get insight into device innovation trends and upcoming changes in the medical device regulations.
for successfully executing regulatory inspections by providing industry best practices. Panel discussions led by the former FDA office bearers and industry experts will provide a set of comprehensive strategies on how to prepare for and manage an FDA inspection, including how to follow-up and closing out 483s or Warning Letters. Attending this summit will enable you to improve and better prepare for your next inspections.
FDA compliant quality management systems. Attend this summit to learn how to develop and implement effective, consistent and reliable quality management systems. Ex-FDA officials and senior company executives will share thoughts and ideas to improve the performance of your current system.
with leading minds in the industry. Attendees will get to network with the prominent decision makers in the industry to exchange ideas, offer thoughts and know-how, and share experiences. Joining this summit will offer a unique opportunity to the attendees to market their offerings and identify new business opportunities.
the current state of medical device laws and technology and government oversight. Panel comprising of some of leading medical device experts and veterans will discuss the recent changes to the regulatory environment for the medical device industry and how these changes will impact the approval of new devices. Attendees will gain insight into the current issues and future challenges in the industry. Join this summit to hear from the experts who have extensive experience in all aspects of medical device including R&D, manufacturing quality assurance, approval and commercialization process.
factors for successful medical device commercialization. Discussions with industry veterans through real case studies will help medical researchers, healthcare professionals, industrialists and entrepreneurs better understand the criterias for successful commercialization of medical devices. This summit also offers numerous opportunities for medical device companies and suppliers to showcase their products and services to potential customers, generating leads and growing their businesses.
risk management strategies for the safe, effective and efficient use of medical devices. Medical device professionals will join together to share their knowledge and best practices for implementing good risk management principles within the industry. Attending this summit will help you to develop a robust and integrated risk management plan to improve quality management system.

Find out who had attended the Medical Device Summit in 2015, 2016 and 2017 by completing the short form below.


Why you should attend this summit

  • Future Trends of Medical Device Regulation, Risk Management, UDI, Recall Complaint Management etc.
  • Listen from FDA/CDRH Directors:
    • What is Critical to Quality
    • Get Update on FDA compliance
  • Listen from FBI:
    • Cyber Security Risks
  • Learn More about Medical Device Global Regulatory Landscape and Off-label Promotion
  • Explore Upcoming Changes in Medical Devices under Trump Administration
  • Change Management
  • Criteria for Supplier Quality Agreement
  • Establishing a Medical Device Security Program
  • Panel Discussion
    • FDA Warning Letter
    • FDA Enforcement
    • FDA Interaction

Who Will Benefit?

  • Quality Assurance/Quality Control
  • Manufacturing and Contracting
  • Supply Chain Management
  • Import/Export
  • Sales, Marketing and Business Development
  • IT and Software
  • Risk Management and Product Lifecycle Management
  • Executive Management
  • Regulatory Affairs
  • Research and Development
  • Engineers
  • Scientists
  • Documentation
  • Compliance Officers
  • Clinical/Lab
  • Consultants/Service Providers/Suppliers

Sponsors, Exhibitors and Media Partners

Media Partners


The 4th Annual Medical Device Summit will include the following:

Keynote Addresses

Leading medical device experts and company executives give their view of the current issues and future challenges in the industry.

Focused Workshops

Expert-led workshops that will help those medical device professionals starting out in their careers and even more senior professionals who need to brush up on new technologies, regulations, processes and more.

Panel Discussions

Panels comprising some of the well-known thinkers and innovators in medical device technology, regulatory compliance and quality will discuss and debate the hottest issues that are affecting the industry. Attendees will be able to interact with panel members during these debates and get unparalleled insight into the state of the industry.

Networking Sessions

Attendees will get to interact with and meet the leading decision makers in the industry in order to exchange ideas, discuss business opportunities and share strategies in focused, small groups.

Multiple Tracks

The Summit will have event tracks dedicated to topics affecting each division/segment of the medical device industry

Exhibitors’ Stalls

A unique opportunity for medical device companies both big and small to market their offerings and identify new business opportunities.

Post-Event Community Access

Attendees will get access to an online community that ensures they can continue to build on the networking opportunities and interest that began during the event.

8:00 - 8:30 am

Registrations and Networking Breakfast

8:30 - 8:45 am

Welcome Speech with an Introduction of 4th Annual Medical Device Summit 2018

8:45 - 9:10 am

Adequate Directions for Use "in the Age of AI and Watson"

Stephen Allan Weitzman, Editor in Chief at FDA Information Repository, IRAI
9:10 - 9:40 am

Medical Devices and the Future of Outcomes Centricity

Peter Pitts, Chief Regulatory Officer, Adherent Health, LLC
9:40 - 10:20 am

Recall  FDA Advice  Recall Best Practices & update:

CDRH Invited
10:20 - 11:00 am

Medical Devices under Trump Administration

Larry Stevens, Senior Quality & Regulatory Consultant, THE FDA Group, LLC
11:00 - 11:30 am

FDA Communication Power Tools

Kwame Ulmer, Medical Device Executive | Angel Investor, Principal, Ulmer Ventures
The US Food and Drug Administration offers a range of mechanisms to communicate with premarket review staff. The timing of communication and best practices to ensure both parties understand each other's messages is not well understood. Manufacturers regularly under-estimate the time and preparation required for effective communications for premarket applications and postmarket communications. Kwame Ulmer will highlight effective communication with FDA in a comprehensive manner to include the power tools that can be used immediately when seeking clearance, approval and effective compliance remediation.
11:30 - 11:45 am

Networking Break

11:45 - 12:25 pm

FDAs Changing Views on Mobile Medical Apps and Clinical Decision Support Software

Michael A Swit,Principal, Law Offices of Michael A. Swit
12:25 - 1:30 pm


1:35 - 2:05 pm

Global Regulatory Landscape (US , EU and APAC) : Whats on the Horizon?

Darin Oppenheimer, Director Regulatory, CMC, & Combination Products, Merck
Track A - Sessions
Track B - Sessions
2:10 - 2:35 pm

Medical Device Single Audit Program (MDSAP) - Can I Really Get Down to Just One Audit?

Future of Polymers in Medical Devices

Syed H. Askari PhD, President, Medical Device Biopolymer LLC

2:40 - 3:05 pm

Agile for Medical Devices - A New Day Dawns

Brian Shoemaker, Principal Consultant, ShoeBar Associates

Some medical device entrepreneurs see the Agile approach a a way to escape the heavy, slow, expensive, document-centered development methods of the past. However, many who are responsible for QA and RA are still skeptical that Agile teams can develop rapidly and still be compliant. This presentation will:
  • Briefly examine the disagreements over an Agile approach
  • Review where Agile is already being applied in medical device work
  • Discuss how an Agile approach fits - and is superior - in the ISO 13485 quality context
  • Examine key areas of concern: risk management, human factors, and design review
  • Describe various pitfalls related to Agile and how to avoid them

If properly understood and applied, an Agile approach can breathe new life into the medical device industry.

Establishing a Medical Device Security Program

Robert Mai, Senior Manager, Deloitte & Touche LLP
Nick Sikorski, Manager, Deloitte & Touche LLP

Short Abstract: The past decade has seen an intertwined evolution of medical device security threats, regulatory and customer requirements, and the emergence of industry leading practices. Given the impact of these evolving factors, the future of healthcare will continue to be driven by technological advancements, customer demands for functionality and ease of use, and regulatory oversight. Unfortunately, leaving security as an afterthought for decades, combined with the long life of medical devices in the field, has caused many connected medical devices on the market today to have significant cybersecurity vulnerabilities that can be exploited to gain unauthorized access to data or directly impact patient safety. Historically, many medical device manufacturers and healthcare delivery organizations were behind the maturity curve in terms of building security safeguards into the connected medical devices that were sold and managing the postmarket risks upon fielding. Although there have been impactful improvements over the past decade, limited resources have made it difficult to comprehensively address medical device cybersecurity risks throughout the device lifecycle through end-of-life. A mature Medical Device Security Program can increase effectiveness and consistency in the execution of security mitigations, including improved collaboration and communication between medical device manufacturers and healthcare providers. This session will explore key positive and negative industry trends and a programmatic approach medical device manufacturers and healthcare delivery organizations can take to secure connected medical devices throughout their lifecycle and reduce risk to patient safety and information security.
3:05 - 3:45 pm

Post Marketing Safety Reporting for Combination Products

Matt Matuszewski, Director Marketed Combination Product Quality, The Janssen Pharmaceutical Companies of Johnson & Johnson
3:45 - 4:00 pm

Networking Break

4:00 - 4:40 pm

Health Hazard Evaluations and Adverse Event Reviews - (Remote)

Adam Saltman, Medical Officer, Office of Compliance, Center for Devices and Radiological Health, FDA
4:40 - 4:50 pm

Closing Mark - Next Day Plan

8:00 - 8:30 am

Registration and Breakfast

8:30 - 9:00 am

Why Government cannot fix the Healthcare Quagmire - Keynote Speech

Tom Loker, Businessman | Author | Speaker, Startup Consultant and Advisor, SYDK.ORG
Tim Henning, Account Manger, Providence Health & Services, Philips Medcial
After Billions of Dollars our healthcare system is still not fixed? Are you curious why the government can’t fix our healthcare system?
Tom Loker and Tim Henning hosts of HealthReform 2.0 Show and Podcast will take you on an exploration of where we are, how we got here and why the government can’t fix our healthcare system. They will review some of the history, decisions and policies that have built the U.S. Healthcare System into an irreconcilable quagmire that is not a system at all, but a self-predatory and hostile economic environment.
They will discuss how the patient is on the “outside looking in” to a totally non-transparent closed environment that most of the time finds it very easy, convenient, profitable and cost effective to forget the patient.
We will explain why the government cannot fix this mess. How when the government steps in they have only increased cost and for the most part harmed care. We will conclude with how WE, the patients, can actually effect change, provide solutions and put us all at the center of our own healthcare universe.
9:00 - 9:30 am

Medical Devices and the Future of Outcomes Centricity - Keynote Speech

Peter Pitts, Chief Regulatory Officer, Adherent Health, LLC.
9:30 - 10:00 am

Medical Device Enhancements - Keynote Speech

FDA Presenting
10:00 - 10:25 am

Effective Internal Auditing for Superior Quality Systems

Vesna Janic, Director of Quality/Regulatory, StarFish Medical and ViVitro Labs Inc.
10:25 - 10:55 am

21st Century CURES Act and ISO 62304:2016 : How the changes impact Software Design and Development - Keynote Speech

Catherine Casab,MS Business Management, BSCS Quality Assurance Director, Third Pole Therapeutics
10:55 - 11:10 am

Networking Break

11:10 - 11:40 am

FDA Upcoming Electronic Submission Process

11:40 - 12:15 pm

FDAs Changing Views on Mobile Medical Apps and Clinical Decision Support Software

Michael A Swit, Principal, Law Offices of Michael A. Swit
12:15 - 12:45 pm

Global Regulatory Landscape (US, EU and APAC): Whats on the Horizon?

Darin S. Oppenheimer, DRSc, RAC, FRAPS, Executive Director, Head Drug Device Center of Excellence, Merck
12:45 - 1:45 pm


Track A - Sessions
Track B - Sessions
1:50 - 2:30 pm

The EU Regulations - Prepare for Implementation

Human Factors Compliance: Just Another Hoop or Good Business?

2:35 - 3:00 pm

Digital Health & Medical Devices

Practical Lessons from 16 years of the Agile Community

3:00 - 3:15 pm

Networking Break

3:15 - 3:40 pm

Learning From FDA Warning Letter - How to Stay Out of Trouble? - Keynote Speech

Lifei Liu, PhD, RAC, Associate Director, Regulatory Affairs, Abbott
3:40 - 4:20 pm

Post Marketing Safety Reporting for Combination Products

Susan Neadle, Head, Combination Products Center of Excellence, Sr. Director, Quality Engineering & Design-to-Value, Product Quality Management (PQM), Janssen Pharmaceuticals Companies of Johnson & Johnson
4:20 - 4:35 pm

Vote of Thanks & Participation Certificate Distribution

2018 Summit Speakers

Past Speakers from FDA, FBI and FDA Information Repository (IRAI)


Terri Jollymour

(Sr. Director, Operations Readiness & Convergence
Johnson & Johnson Corporate Supply Chain Quality & Compliance)

Pat Baird

Regulatory Head of Global Software Standards, Philips

Nick Sikorski, CISSP

Manager, Deloitte & Touche LLP

Robert Mai

Senior Manager, Deloitte & Touche LLP

Tom Loker

(Businessman | Author | Speaker, Startup Consultant and Advisor SYDK.ORG, Contributor to California Political Review)

Dr. Ron Weissman

(Chairman, Software SIG, Band of Angels)

Stan Mastrangelo

Technical Committee Member of working group on ISO 31000, ISO 14971, and ICH Q9 Standards, Professor, Center for Applied Health Sciences, Virginia Tech University

Daphne Walmer

Thought Leader/Expert/Consultant in Medical Device Labeling and Technical Communications

Michael Weickert

Strategic & Entrepreneurial Executive, Trail-blazing Leadership in Biotech, Medical Device & Pharmaceutical Business

David Nettleton

Industry Leader, Author, and Teacher for 21 CFR Part 11, Annex 11, HIPAA, Software Validation, and Computer System Validation

Brian Shoemaker, Ph.D.

Principal Consultant, ShoeBar Associates

Geetha Rao

CEO, Springborne Lifesciences

Dan O'Leary

President at Ombu Enterprises, LLC

Nancy Van Schooenderwoert

President, and Managing Partner Development Practice at Lean-Agile Partners

Minda Wilson

Founder, Affordable Healthcare Review

Keith Morel,Ph.D.

VP, Regulatory Compliance, Qserve Group US Inc.

Roy Wallen

President & CEO, Directional Healthcare Advisors, LLC

Steven Grossman

President, HPS Group, LLC

James Edward Ledlum, Jr

Director Corporate Supplier Quality, Hologic, Inc

Christine Santagate, RAC

Director, Boston Operations

Virginia A. Lang, Ph.D.

President & Chief Scientist, HirLan, Inc.

Peter Pitts

Chief Regulatory Officer, Adherent Health, LLC.

Scott Phillips

President Starfish Medicals

Fletcher Wilson

CEO and Founder, InterVene Inc

Patrick Rousche

Co-Founder and Chief Scientific Officer, Hemotek Medical, Inc

Roni Cohen

Director of the Microbiology & Chemistry Division, HYLabs

Nancy Knettell

Principal, Signet Medical Systems

Susan W. Neadle

Sr. Director, Janssen Pharmaceuticals

Rick Williams

Partner, Newport Board Group New England Practice, Chairman of Point Care Technology, Board member of Amorphex Therapeutics

Mitch Levinson

Founder, President & CEO, Cerebrotech Medical Systems

Gunjan Sinha

Executive Chairman, MetricStream

French Caldwell

Chief Evangelist, MetricStream

Kevin Fleming

National Healthcare Managing Director, Newport Board Group

Julia Rasooly

Founder and CEO, PuraCath Medical Inc

Andrew Pfeifer

Account Executive, REED TECH

Haley Lentz

GUDID Submission Subject Matter Expert, Reed Tech

Angela Bazigos

CEO, Touchstone Technologies Inc

Jon Speer

Founder and VP of QA/RA, greenlight.guru

Joe Franchetti

FDA Regulatory Compliance Specialist, JAF Consulting Inc

Eduardo Cervantes

President & CEO, Morf Media Inc
Robin Newman Director, Office of Compliance, Center for Devices and Radiological Health, FDA

Robin Newman is the Director for the Office of Compliance at FDA's Center for Devices and Radiological Health. Dr. Newman has 25+ years of senior level clinical/regulatory and compliance management experience in new product research and development. She's served as a senior level executive and consultant for regulatory strategy, clinical trial design and execution, standards and SOP development, quality system management and compliance, medical and technical writing, customer/patient interface and education, and management of Data Safety Monitoring Boards. Prior to joining FDA, Dr. Newman served as the Vice President of Quality Management for Siemens Healthcare Diagnostics, where she managed a multidisciplinary quality management and regulatory team and functioned as the primary representative for AdvaMedDx and the Diagnostic Tests Working Group. She holds a B.S. and M.S. in Nursing from the University of Texas, an Ed.D. from The George Washington University's Executive Leadership Program, and holds certifications as a Pediatric Nurse Practitioner, in regulatory affairs (RAPS), and as a CCRA (ACRP).

Adam Saltman, MD PhD Medical Officer, CDRH/Office of Compliance

Adam E Saltman MD PhD is a Medical Officer in the Office of Compliance, Center for Devices and Radiological Health, at the Food and Drug Administration. He has worked with the FDA in both the premarket and postmarket arenas as a clinical reviewer since 2008. His primary responsibilities there now focus on the compliance medical device removal and correction process, as well as incorporating clinical benefit risk evaluations in recall and potential recall situations. Dr. Saltman consults regularly on clinical risk evaluations, device recall classifications, and public-facing FDA and manufacturer communications. Dr. Saltman left his clinical practice in cardiothoracic surgery in 2016, during which he held a special interest and key opinion leadership in the surgical treatment of atrial fibrillation. He has published more than 100 peer-reviewed articles, served on several journal editorial boards, and conducted competitively funded research projects. Dr. Saltman also holds an appointment of Clinical Associate Professor of Surgery at the Ohio University Heritage College of Osteopathic Medicine, where he teaches residents and medical students. He received his MD and his PhD degrees from Columbia University, his MS in health informatics from the University of Illinois at Chicago, and is certified as a Quality Improvement Associate by the American Society for Quality.

Ronny Brown Branch Chief for Medical Device Recalls, FDA

Stephen Allan Weitzman Editor in Chief, FDA Information Repository, IRAI

Stephen Weitzman has been involved in healthcare matters for the past 45 years as a practicing lawyer and science consultant in the pharmaceutical, medical device, and food industries. He is a pioneer of the use of computers in legal and science research and litigations support systems from mainframe to personal computers. In the early 70’s he set up complex litigations support systems for fortune 100 corporations and their associations in the FTC nutrition advertising proceeding. Those systems blended data from exhibits, attorney files, science literature, surveys, and court decisions, including text and image files. He worked with Brower Murphy who created the first CD-ROM for data on a Toshiba music disc player, the Library of Congress Catalog as Library Corporation. Steve created the first CD-ROM on a government agency (FDA) in 1984, including internal FDA documents and manuals relating to training drug reviewers to enforcement manuals. He also built the FDA’s original website section on regulation enforcement.

In recent years he has also been involved in prosecuting major civil fraud litigation and patent infringement. The fraud litigation involved drug diversion and potential counterfeiting. The patent matters relate to information technology systems.

Currently focuses on the Medical Informatics for healthcare issues related to establishing a functional national health information infrastructure for sharing medical records for research, safety surveillance, and personalized medicine.

Casper E Uldriks Former Associate Center Director, FDA, CDRH

Casper (Cap) Uldriks, through his firm “Encore Insight LLC,” brings over 32 years of experience from the FDA. He specialized in the FDA’s medical device program as a field investigator, served as a senior manager in the Office of Compliance and an Associate Center Director for the Center for Devices and Radiological Health. He developed enforcement actions and participated in the implementation of new statutory requirements. His comments are candid, straightforward and of practical value. He understands how FDA thinks, how it operates and where it is headed. Based on his exceptionally broad experience and knowledge, he can synthesize FDA’s domestic and international operational programs, institutional policy and thicket of legal variables into a coherent picture.

Rita Hoffman RAC, Managing Partner, Regs & Recall Strategies, Former Branch Chief, Recalls, CDRH, FDA

Rita Hoffman, RAC. Managing Partner Regs & Recall Strategies, LLC .Ms. Hoffman has more than 36 years of FDA experience across the device, drug and veterinary industries. She has an intimate understanding of FDA regulatory and compliance issues from the perspective of both FDA and regulated industry. As an FDA compliance consultant, she provides clients with regulatory insight, advises on critical compliance deficiencies, performs compliance and new product audits, provides insight and guidance on recall strategies to the medical device industry, and advises on jurisdiction determinations for combination products.

Ms. Hoffman retired from the FDA in January 2011 as the Recall Branch Chief for the Center for Devices and Radiological Health (CDRH), where she was responsible for oversight and review for all medical device recalls. Ms. Hoffman held several positions including the Center for Drug Evaluation and Research (CDER) Jurisdiction Review Officer (providing guidance on drug/device product designation, combination products and co-packaging), Acting Associate Ombudsman, Small Business Liaison, and was a Policy Analyst for eight years in the Office of the Commissioner. She served as co-chair of RAPS’ Baltimore/Washington Metropolitan Area Chapter for 2-terms, and in 2008 was presented with the Special Recognition Award by RAPS.

Daniel L. Aisen Quality Assurance. Regulatory Compliance, Proven Leadership, Former FDA Field Investigator and Former Public Health Inspector Naval Chief Hospital

Pat Baird Regulatory Head of Global Software Standards, Philips

Nick Sikorski Manager, Deloitte & Touche LLP

Nick is the Global Program and Solutions Leader for Deloitte & Touche’s Medical Device Safety and Security (MeDSS) practice, which focuses on securing connected medical devices and other life sciences products. He primarily works with Medical Device Manufacturers and Healthcare Providers designing, developing, and implementing enterprise level Medical Device Security Programs. Nick also works at a device level defining security requirements, developing product security risk assessment frameworks, and conducting product security risk assessments. Beyond consulting, Nick is active across the life sciences industry through his work on AAMI’s medical device security work group and through conference presentations and panels.

Roy Wallen President & CEO, Directional Healthcare Advisors, LLC

Roy Wallen leads Directional Healthcare Advisors, LLC as its CEO. He has served in leadership roles for new product initiatives for more than 25 years in medical technology companies ranging from pre-revenue start-up to multi-billion, global concerns. With an undergraduate degree in electrical engineering and a biomedical focus, as well as graduate studies in biomedical engineering and business, Roy has spent his career managing existing businesses for sustainable profits and bringing new technologies out of the laboratory and into clinical use. He has led successful commercial launches of new healthcare technologies in the United States, Europe, and Asia. Roy has published 13 peer-reviewed papers and 20 abstracts and short papers related to healthcare technology and its implementation.

Stan Mastrangelo Technical Committee Member of working group on ISO 31000, ISO 14971, and ICH Q9 Standards, Professor, Center for Applied Health Sciences, Virginia Tech University

Stan Mastrangelo has over 30 years of professional work experience in Quality Assurance of medical devices, pharmaceuticals, and foods. Stan has held positions such as Senior Quality Engineer, Corporate Quality Assurance Auditor, Plant QA Manager, QA Director, and Consultant. Stan was a member of the ANSI Executive Standards Board. Stan has had extensive involvement in the development of International Risk Management Standards. Stan was a member of the ISO Joint Working Group for Risk Management of Medical Devices (that developed ISO/IEC14971). Stan was a committee liaison to the ISO Technical Management Board Joint Working Group on Risk Management that developed ISO 31000 which is the Risk Management Standard for all sectors. Stan was on the US PhRMA (Pharmaceutical Research and Manufacturers Association) Team that supported the development of ICH (International Conference for Harmonization) Standard Q9 titled Quality Risk Management for Pharmaceuticals. Stan also served on various IEC Standards Teams related to IEC 60601, IEC 80001 and Risk Management in the Software Lifecycle. Stan is an Adjunct Professor at Virginia Tech and was a co-developer of a Masters Degree Program in Medical Product Risk Management. Stan is on the Risk Management Committee for the IECEE.

Peter Pitts Chief Regulatory Officer, Adherent Health, LLC.

Peter Pitts is President of the Center for Medicine in the Public Interest. A former member of the United States Senior Executive Service, Peter was FDA's Associate Commissioner for External Relations, serving as senior communications and policy adviser to the Commissioner. He supervised FDA's Office of Public Affairs, Office of the Ombudsman, Office of Special Health Issues, Office of Executive Secretariat, and Advisory Committee Oversight and Management. He served on the agency's obesity working group and counterfeit drug taskforce and is a Special Government Employee (SGE) consultant to the FDA's Risk Communications Advisory Committee.

Specific areas of global policy expertise include FDA policy and process, healthcare technology assessment and reimbursement issues, biosimilar development, Rx-to-OTC switching, risk management plans, GMP policies, pharmacy education programs, drug safety, DTC/ItP, Critical Path, personalized medicine, clinical trial transparency, IP protection, FDA reform, drug importation, counterfeiting, genetically modified food issues, food safety and security, recalls, nutritional labeling.

In 2010, he was named by Modern Healthcare magazine as one of the 300 most powerful people in American healthcare.”

His comments and commentaries on health care policy issues regularly appear in The New York Times, The Los Angeles Times, The Washington Post, The Wall Street Journal, The Financial Times, Health Affairs, The Boston Globe, The Washington Times, The Chicago Tribune, The Chicago Sun Times, The San Francisco Examiner, Investor's Business Daily, The Baltimore Sun, The Economist, Nature Biotechnology, The Journal of Life Sciences the BBC World Service, Fox News, and The NewsHour with Jim Lehrer, among others.

Steven Grossman President, HPS Group, LLC

Steven Grossman is President of HPS Group, LLC, a consultancy that provides strategic counsel, analysis and advocacy on regulatory and policy issues involving the U.S. Food and Drug Administration. Mr. Grossman serves on the Board of Directors of the National Organization for Rare Disorders (NORD) and sits on the board’s executive committee. He is also a founder and deputy executive director of the Alliance for a Stronger FDA, a multi-stakeholder coalition that advocates for increased resources for the FDA. Earlier in his career, Mr. Grossman was Deputy Assistant Secretary for Health at HHS and Health Staff Director and Counsel to the Senate HELP Committee.

Brian Shoemaker Ph.D., Principal Consultant, ShoeBar Associates

Brian Shoemaker provides consulting services and training in computer system validation, software quality assurance methodology, and electronic records and signatures. His projects have included validating process-equipment software, validating embedded medical-device software, developing software quality systems, assisting companies through regulatory-compliance projects, and evaluating systems for 21 CFR Part 11 compliance. His clients have included firms in the medical-device fabrics manufacturing, plastics molding, contract lyophilization, outsourced medical device engineering, clinical trial software development, dental prosthetics, and bone-repair implant fields. He has worked with companies in Germany and Switzerland as well as the U.S.

Previous to founding ShoeBar Associates, Brian served as Quality Assurance Manager at PPD Informatics (now CSS Informatics), QA/Validation for Doxis, Inc., and Systems Engineering Manager at Behring Diagnostics, Inc. Brian earned his Ph.D. in chemistry from the University of Illinois; he has achieved the ASQ Software Quality Engineer certification.

Virginia A. Lang, PhD President & Chief Scientist, HirLan, Inc.

Virginia started in the medical research field as a Coordinator of Research at the Clinical Research Unit Kennedy Institute of Johns Hopkins Medical Center. She was responsible for the initiation, coordination, and management and/or analysis of research projects in the Clinical Research Unit. These projects were funded by various Federal Government Agencies. Subsequent to Johns Hopkins Medical Center, Virginia entered the field of Human Factors through the doctoral program at SUNY Binghamton. Virginia held a fellowship at the Aeromedical Research Laboratory of the United States Air Force at Wright-Patterson AFB, Dayton, Ohio and a fellowship at NASA. Her research dealt with cognitive factors that differentially affect the characteristics of visual displays. Applications of this research are directly related to various medical devices and software applications providing Medical Device Human Factors by HirLan clients with 30 years of Human Factors experience.

In addition, Virginia has extensive experience in the areas of product design, Customer Centered Participatory Design processes, and product lifecycle management. She is also known in the Human Computer Interaction and Usability Communities for her innovative techniques for collecting and incorporating user/customer feedback throughout the product lifecycle. In July 2014, Virginia founded and established the HirLan Institute of Human Factors with labs in Carlsbad, California and a Consortium arrangement in London, UK. In February 2013, Virginia founded HirLan International SA, a Geneva, Switzerland based company. Both HirLan and HirLan International have been supporting Top Ten pharma/medical device companies, as well as, start-ups with consulting and testing services. These services are in conjunction with their clients' FDA 510(k) and CE mark applications.

Virginia holds a PhD in Cognitive-Experimental Psychology from SUNY Binghamton, and a Master of Science (ABT) in Applied Technology, Systems Science from SUNY Binghamton.

Roni Cohen Director of the Microbiology & Chemistry Division, HYLabs

Scott Phillips President, Starfish Medicals

Scott holds a degree in Engineering Physics from the University of British Columbia. Prior to starting StarFish, he worked in diverse areas such as lithium battery development and manufacturing, UV spectroscopy instrumentation and hi-fi audio speakers. Under his leadership StarFish has grown from being a highly motivated team working on one project at a time to a diverse professional organization with clients around the world and 100% focus on medical devices.

Darin Oppenheimer Executive Director, Head Drug Device Center of Excellence, Merck

James Edward Ledlum, Jr. Director Corporate Supplier Quality, Hologic, Inc

SSA Steven T. Sciavolino Mission Critical Engagement Unit , Cyber Division, FBI

Christine Santagate, RAC Director, Boston Operations

Dan O'Leary President at Ombu Enterprises, LLC

Is the President of Ombu Enterprises, LLC, a company offering training and execution in Operational Excellence, focused on analytic skills and a systems approach to operations management. Dan has more than 30 years experience in quality, operations, and program management in regulated industries including aviation, defense, medical devices, and clinical labs. He has a Masters Degree in Mathematics; is an ASQ certified Quality Engineer, Reliability Engineer, and Six Sigma Black Belt; and is certified by APICS in Resource Management.

Nancy Knettell Principal, Signet Medical Systems

Nancy Knettell has over 30 years in combined Mechanical Design, Software Development, and Systems Engineering experience primarily in the Medical Device industry as a Software Verification Validation/Systems Engineer.

Along with her Senior Level Management experience with cross-functional Program Teams for such companies as EMC and United Technologies, Nancy has also consulted to major medical companies such as Smith and Nephew, Philips Medical, CR Bard, Kollsman Medical, Applied Biosystems, Deka Research, Avedro and Hologic.

But, for Nancy, involvement in medical device development is a personal issue. Having lost her father at an early age to heart disease, she now wants to work to help other people facing such life threatening events. It is her mission to advance the potential for life-saving medical devices through the use of quality based engineering systems.

Nancy's team at Signet can help you implement a Software Quality System rapidly and to full compliance with both current US and European ISO 62304 FDA Software Validation Requirements.

Signet can also help your company prevent costly errors due to inexperience developing software for medical devices by leveraging her company's extensive software systems development know-how and comprehensive design and documentation resources ready for your immediate implementation.

Nancy hold a Bachelors of Science in Information Technology from UMASS Lowell (graduated magna cum laude.) She is also an inducted member of Phi Beta Kappa National Honor Society. Nancy, along with her husband, are avid horse sport enthusiasts.

Nancy Van Schooenderwoert President, and Managing Partner Development Practice at Lean-Agile Partners

Robert Mai Senior Manager, Deloitte & Touche LLP

Robert is a Cyber Risk senior manager and has over 15 years of experience with information technology, regulatory compliance, and business process & technology controls across various industries. He has served his clients in a wide range of cyber risk roles which included: security, privacy, and compliance assessments; developing cyber strategies / roadmaps / programs based on leading industry requirements (HIPAA, NIST, ISO, PCI, SOX, etc.); backfilling for strategic security roles within organizations; and leading security work streams on large scale, multi-million dollar business transformation efforts and enterprise resource planning technology implementations.

Robert is also a portfolio leader for Deloitte’s Medical Device Safety and Security (MeDSS) practice. In this role, he focuses on helping life science and healthcare clients address security of medical devices throughout their product lifecycle.

Robert received a Bachelor of Arts degree in Economics from the University of California, Los Angeles. In addition, he holds numerous certifications including the Certified Information Systems Security Professional (CISSP), Certified Information Systems Auditor (CISA), and Certified Cloud Security Professional (CCSP).

Martyn Gross CEO, Skylit Medical

Daphne Walmer Thought Leader/Expert/Consultant in Medical Device Labeling and Technical Communications

Daphne Walmer is a former Director of Technical Communications at Medtronic who pioneered the use of electronic manuals in the medical device industry. Her group obtained approval to test eIFUs in the European Union for 10 years before their approval in 2013. She helped review the EU regulation for the industry, and led the effort for Medtronic to comply with its requirements. She currently consults in the areas of management of user documentation, translation and localization, and component content management systems.

Fletcher Wilson CEO and Founder, InterVene Inc

Fletcher Wilson is the Founder and CEO of InterVene, Inc., a start-up medical device company working in the peripheral venous space. Fletcher raised a Series A with subsequent closings from an investor base of over 60, including a corporate strategic, two venture capital firms, three angel groups, and various individuals. He is the first named inventor on two issued patents, and numerous active applications in the interventional venous space. Prior to InterVene, Fletcher was a Stanford Biodesign Fellow, where he and his teammates identified the clinical need and initial solution that would become InterVene. Prior to Biodesign, Fletcher was an R&D engineer at a two person device start up, InSite Medical, and an R&D intern at Boston Scientific. Fletcher received his Master's degree in Mechanical Engineering from Stanford University and his Bachelor's Degree in Mechanical Engineering from the University of Pennsylvania.

Marisa White Lead Consumer Safety Officer, Division of Bioresearch Monitoring, Office of Compliance, CDRH

Marisa White is the Regulatory Misconduct & Complaints Lead CSO for the Division of Bioresearch Monitoring (DBM) in the Office of Compliance at FDA's Center for Devices and Radiological Health (CDRH). Marisa started at the FDA in the International Operations Branch under the Office of Regulatory Affairs (ORA), where she was involved in the coordination of FDA foreign inspections as the Bioresearch Monitoring (BIMO) Program Team Lead. Prior to FDA, Marisa worked at the New York Blood Center as a Research Assistant before becoming a Clinical Research Program Coordinator at Johns Hopkins University in the Oncology Department, where she managed data and regulatory requirements for various multi-center protocols, with coordinating center responsibilities. Marisa also served as a Sr. Research Program Coordinator for the Leukemia Research Group with responsibilities for training and SOP writing/updates. After Hopkins, she held several roles at a clinical research organization (Covance, Inc.), one of which was a Clinical Research Associate (CRA) involved the set-up and monitoring of clinical trials. Marisa holds a BS in Biotechnology & minor in Biochemistry from Rutgers University and a CCRP certification from SoCRA.

Seth D. Carmody,Ph.D Cybersecurity Project Manager, CDRH

Dr. Carmody is currently working as the Cybersecurity Project Manager in the Office of the Center Director, Emergency Preparedness/Operations & Medical Countermeasures. Seth also serves as a subject matter and policy expert with CDRH's Cybersecurity Working Group.

Seth joined the FDA's Center for Devices and Radiological Health in 2011 as a medical device reviewer in the Division of Chemistry and Toxicology Devices where his duties focused on premarket approval of diabetes-centric devices and software recalls.

Bakul Patel Associate Director for Digital Health, FDA

BAKUL PATEL is Associate Director for Digital Health, at the Center for Devices and Radiological Health (CDRH), at the Food and Drug Administration (FDA). Mr. Patel leads regulatory policy and scientific efforts at the Center in areas related to emerging and converging areas of medical devices, wireless and information technology. This includes responsibilities for mobile health, health information technology, cyber security, medical device interoperability, and medical device software.

Mr. Patel is the FDA liaison between the Federal Communications Commission (FCC) and the Office of the National Coordinator (ONC). Since its inception in 2013, Bakul chairs the International Medical Device Regulators Forum (IMDRF) “software as a medical device” working group, a global harmonization effort.

Before joining FDA, Mr. Patel held key leadership positions working in the telecommunications industry, semiconductor capital equipment industry, wireless industry and information technology industry. His experience includes Lean Six Sigma, creating long and short-term strategy, influencing organizational change, modernizing government systems, and delivering high technology products and services in fast-paced, technology-intensive organizations.

Mr. Patel earned an MS in Electronic Systems Engineering from the University of Regina, Canada, and an MBA in International Business from The Johns Hopkins University

Chrissy Cochran Acting Director, Division of Enforcement and Postmarketing Safety, FDA

Bill MacFarland Director, Division of Enforcement B, Office of Compliance, FDA/CDRH

William MacFarland is the director of the Division of Enforcement B within the Office of Compliance. In this position, he is responsible for overseeing the division's 33 member review staff who review PMA Manufacturing Sections, Establishment Inspection Reports, recall classifications and compliance cases.Previously, Mr. MacFarland worked in CDRH's Office of Device Evaluation as both a reviewer and Deputy Division Director in the Division of Cardiovascular Devices. Prior to his current work at FDA he was a consultant with Quintiles Consulting where he was responsible for providing clients with strategic regulatory guidance and managed their 510(k), PMA and IDE projects. Additionally, he developed medical product test strategies, provided review of non-clinical protocols and reports, and provides guidance on compliance with Design Controls throughout medical device development. Mr. MacFarland has also worked for Angiosonics, Inc. of Morrisville, NC as Director of Regulatory Affairs.

Mr. MacFarland received his MBA from University of Maryland in College Park, MD, and his MS in Biomedical Engineering from Case Western Reserve University in Cleveland, OH. He received his BS in Electrical Engineering from Clarkson University in Potsdam, NY. Currently he maintains a Professional Engineers license in Maryland and is an ASQ Certified Quality Engineer, Certified Biomedical Auditor, Certified Software Quality Engineer, Certified Six Sigma Black Belt, Certified Manager of Quality/Organizational Excellence and Certified Reliability Engineer.

Erin Keith Director, Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices, CDRH, FDA

Erin Keith is the Director for the Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices (DAGRID) in the Office of Device Evaluation (ODE) at the Center for Devices and Radiological Health (CDRH). As the DAGRID Director, Ms. Keith provides executive oversight of the division’s premarket programs and review policy for a wide-range of medical device product lines; establishes the division strategic priorities; and supervises a diverse staff of medical, engineering and scientific staff. In her management role in DAGRID, she oversees DAGRID’s implementation of a unique risk-management pilot program, the Safety Assurance Case for Infusion Pumps. She also continues to teach on risk management topics, and represents CDRH in international standards development and harmonization activities.

Prior to her current position with DAGRID, Ms. Keith was the Deputy Director for Science and Policy for the Division of Orthopedic Devices (DOD) in ODE from May 2011 to November 2013. In DOD she provided oversight of the division implementation of review policy and scientific review issues. Additionally, Ms. Keith was the Assistant Country Director for Medical Devices at the US FDA New Delhi Office from February 2009 until May 2011. As an Assistant Country Director, Ms. Keith was responsible for analyzing the Indian medical device industry’s capabilities for meeting US regulatory requirements and developing a program to increase the Indian industry’s knowledge of US medical device regulatory requirements.

Cisco Vicenty Acting-Branch Chief, Office of Compliance, CDRH/FDA

Neil Mafnas, LCDR, USPHS, M.S. Assistant Regulator, CDRH/FDA

Lieutenant Commander Neil A. Mafnas is a Regulatory Officer in the United States Public Health Service Commissioned Corps. He is currently assigned to the Medical Device Single Audit Program (MDSAP) Team in FDA's Center for Devices and Radiological Health, Division of International Compliance Operations. As a member of the MDSAP Team, LCDR Mafnas's duties include the creation/development of policy, procedures, training and conducting outreach. Additionally, Neil serves as a Subject Matter Expert and Project Manager for the development/implementation of MDSAP's IT Portal. Neil began his career with the FDA in 2010 as a Consumer Safety Officer (CSO) in the Office of Compliance at the Center for Devices and Radiological Health. As a CSO in the General Hospital Devices Branch, he worked on medical device inspection classifications, recall classifications, medical device complaints and Consent Decrees for Permanent Injunction. Neil also works closely with the Association for the Advancement of Medical Instrumentation as one of the Agency's Quality System Regulation instructors. LCDR Mafnas has been in the Public Health Service since November 2011. Prior to coming to the FDA, he worked as the Safety Manager for a logistics firm. Neil also served in the United States Air Force as an active duty Space and Missile Maintenance Officer from 2001 to 2007. LCDR Mafnas holds a Bachelor's Degree in Biology from the University of Texas at Arlington, and a Master's of Science in Health Sciences from the University of Central Florida.

Ann Ferriter Director, Division of Analysis and Program Operations, CDRH/OC, FDA

James Saviola Deputy Director of Regulatory Affairs (Acting), and Director, Division of Biomedical Research, Office of Compliance, CDRH

Dr. James Saviola joined the Center for Devices and Radiological Health (CDRH) in 1986. He is a Captain in the U.S. Public Health Service and holds consulting staff credentials with the Optometry department at the Walter Reed National Military Medical Center, Bethesda, MD. Jim was a branch chief in the Office of Device Evaluation involved with ophthalmic devices from 1991 until January 2008. He then served three years in the Center Director's Office where he was responsible for helping to promote information exchange within CDRH to better identify and analyze medical device risks and develop public health responses. Jim has been with the Division of Bioresearch Monitoring in the Office of Compliance since January 2011. He's been serving as the BIMO Director since the fall of 2011. Under his direction the division has focusing on developing expertise in various program areas and expanding support of Class II medical device clinical study activities.

French Caldwell Chief Evangelist, MetricStream

One of the foremost thought leaders in IT, French Caldwell has been decisively shaping the GRC market for the last 12 years.

French is a former Fellow and Vice President at Gartner where he led their GRC research, including the influential Gartner Magic Quadrant on GRC, as well as research into disruptive technology. He also worked with the White House and U.S. Naval War College in 2002 to develop the Digital Pearl Harbor war game, the first ever strategic assessment of cyber war strategies. In 2012, the game took on a very real form with the strategic attacks on oil and gas infrastructure in Saudi Arabia and Qatar. French is also a retired naval officer and a nuclear submariner. Post-retirement, French served as a diplomatic liaison to NATO for the post-Cold War Congressional Commission on Roles and Missions of the Armed Forces.

As an academic, French served as a Federal Executive Fellow at the Brookings Institution, an Adjunct Fellow at the Center for Strategic and International Studies, and an Adjunct Professor and Graduate Research Advisor at the George Washington University School of Engineering Management. He has written a book on international law, and has over 400 published research papers.

French has a PhD in Law and Policy, an MA in International Economics, Strategy and Diplomacy, and a BS in Oceanography.

Minda Wilson Founder, Affordable Healthcare Review

Minda Wilson, J.D., is an author, entrepreneur, and a corporate attorney, specializing in healthcare. A recognized expert on the Patient Protection and Affordable Care Act, she consults with clients regarding its proper implementation. She is founder of Affordable Healthcare Review, an educational organization providing information about healthcare legislation, its application, and impact. For more than 20 years, Wilson has worked with companies in the areas of productivity improvement, crisis management, corporate organization, business and financial planning, and fraud detection.

Geetha Rao CEO, Springborne Lifesciences

Andrew Pfeifer Account Executive, REED TECH

Andrew works closely with a team of Subject Matter Experts at Reed Tech to provide submission solutions based on industry needs. Areas of expertise include coordinating with leaders spanning multiple business units in managing complex data submissions to the FDA as well as advising on best practices regarding recent UDI mandates. Additionally, he maintains high levels of Structured Product Labeling and XML conversion practices as well as downstream application and concerns of XML-driven data.

Angela Bazigos CEO, Touchstone Technologies Inc

Angela Bazigos is the CEO of Touchstone Technologies Inc. She has 40 years of experience in the Life Sciences & Healthcare Industries. Experience combines Quality Assurance, Regulatory Compliance, Information Technology, Project Management, Clinical Lab Science, Microbiology, Food Safety and Turnarounds. Past employers / clients include Roche, Novartis, Genentech & PriceWaterhouseCoopers, Public Health Service. Positions include Chief Compliance Officer, http://morflearning.com/angelabazigos/, QA Director, Director of MIS. Co-authored & prototyped 21 CFR 11 guidance with FDA. Co-authored Computerized Systems in Clinical Research w/ FDA http://www1.diahome.org/~/media/4FA562336EBD46C58CDC43A8B7773095.ashx. Patent on speeding up software compliance https://www.google.com/patents/US8266578 . Recently quoted in Wall Street Journal for using training to bring regulatory compliance to the Boardroom http://blogs.wsj.com/riskandcompliance/2015/07/24/using-training-to-bring-compliance-to-boardrooms/ . Comments / collaborates with FDA on new guidance documents. Former President of Pacific Regional Chapter of Society of Quality Assurance. Stanford’s Who’s Who for LifeSciences: http://www.stanfordwhoswho.com/Angela.Bazigos.7144112.html#overview.

Dr. Ron Weissman Chairman, Software SIG, Band of Angels

Dr. Ron Weissman was vice president of strategy and corporate marketing for Verity, a global leader in corporate information retrieval and knowledge management. During his tenure at Verity, the executive team earned the large company "turnaround of the year" award (1999) from the Turnaround Management Association; Verity gained dominant market share and saw its market capitalization grow from $50 million to more than $1.5 billion. Prior to Verity, Ron spent more than five years at NeXT Computer, where he managed European and corporate marketing. In addition to his work in Silicon Valley, he ran academic computing at Brown University and at the University of Maryland, where he was Associate Professor of History. He is the author of two books on the history of Florence during the Renaissance.

Terri Jollymour Sr. Director, Operations Readiness & Convergence Johnson & Johnson

Terri Jollymour is a member of the Operations Readiness & Convergence (ORC) enterprise group, leading strategic efforts in the convergent space for Johnson & Johnson (J&J). Terri works across the three main business sectors: Consumer/McNeil, Janssen Pharmaceuticals, and Medical Device & Diagnostics to ensure safety, quality and sustainability for the convergent space.

Within J&J's Convergent Space, Terri is responsible for comprehensive engagement with project teams to assess and mitigate new product development for product, process and program risks. This spans across early to late development and pre-launch readiness. Terri is also accountable for strategic leadership initiatives in the Supply Chain organization, such as leading the implementation of the Combination Product CGMPs. Terri's group is responsible for ad hoc support for convergent programs, to address specific issues or fill in specific roles on teams. Her group is also responsible for rapid tactical reponse for supply chain and/or quality and compliance mitigation issues across the enterprise. Terri leads the Convergent Network at J&J, which brings all three business sectors together for learning, sharing/leveraging and networking within this innovative space.

For over a decade, Terri has held top leadership roles in the convergent space within J&J. She has been responsible for leading large, complex, convergent product development program teams within J&J's pharmaceutical and medical device & diagnostic sectors. She has been recognized for her outstanding leadership with numerous company recognition awards and executive programs.

Terri earned her degree in Pharmacology at the University of California, Santa Barbara. Prior to J&J, she worked in the diagnostic space at Syva and led controlled release drug-delivery programs (combination products) at ALZA Corporation. She held positions of increasing responsiblities within program management, R&D, analytical sciences and quality assurance over her many years in the health care industry. She is a member of the Healthcare Businesswomen's Association and is a certified Project Management Professional. Terri is married and has three children and three dogs! She enjoys swimming with her masters team, cycling, hiking and skiing. She resides in Northern California.

Haley Lentz (GUDID Submission Subject Matter Expert, Reed Tech)

Haley Lentz is the Account Executive for the Life Sciences Division at Reed Tech. She is responsible for providing a GUDID submission strategy for medical device manufacturers based on a consultative, needs-based assessment.

Haley works closely with a team of Subject Matter Experts at Reed Tech to provide submission solutions based on industry needs. Areas of expertise include coordinating with regulatory affairs leaders in managing complex data submissions to FDA as well as advising on best practices regarding recent UDI mandates. Additionally, she maintains high levels of Structured Product Labeling and XML conversion practices as well as downstream application and concerns of XML-driven data.

During her time at Reed Tech, Haley has collaborated to publish two articles on UDI implementation,"US UDI/GUDID Submission Deadlines: What Medical Device Manufacturers Need to Know" and "Six Recommendations Regarding Upcoming UDI Compliance Dates".

Mitch Levinson Founder, President & CEO, Cerebrotech Medical Systems

Mr. Levinson is a start-up medical device executive with over 30 years of experience developing and bringing revolutionary new products to market. Mr. Levinson started Cerebrotech Medical Systems in 2011 based on a technology developed at UC Berkeley with the goal of improving care for brain injury patients with a noninvasive monitor to detect early stages of cerebral edema and bleeding. Mr. Levinson was the start-up President and CEO for Zeltiq Aesthetics, brought in by the investors, Frazier Healthcare Ventures and Advanced Technology Ventures, as the company's first employee. Zeltiq's groundbreaking cooling technology was licensed from Massachusetts General Hospital for non-invasive fat layer reduction. Mr. Levinson built the company from the ground up and launched the product 3 years later, in what has become widely regarded as one of the most successful medical device launches in the aesthetic space. Zeltiq has quickly become the world's premier fat layer reduction technology and is found in thousands of physician offices in the US and around the world. Zeltiq held its IPO in October of 2011 and by 2014 exceeded a market cap of $1 billion. Prior to Zeltiq, Mr. Levinson was the first technical employee at Thermage, where he led the product development as its founding Vice President of Research and Development. Thermage utilizes a radiofrequency-based technology and was the first device to provide non-invasive skin tightening. That company held its IPO in 2006, and has become a mainstay in aesthetic dermatology and cosmetic surgery physician practices. It is now part of Valeant Pharmaceuticals. Mr. Levinson was also the founding Vice President of R&D at BioSurgical Corporation, developer of a novel applicator for fibrin sealant, acquired in 2000 by Baxter International. Mr. Levinson has served as a product development executive at Nellcor (patient monitoring), Baxter (in vitro diagnostics), and as an engineer at ALCOA Intercon-X, and Hewlett Packard. Many of Mr. Levinson's innovations are represented in his 37 issued U.S. patents with more pending. He earned his B.S. in Engineering Sciences from University of California at San Diego and also holds a MS in Computer Systems from University of Phoenix.

Mark Mitchell SVP Corporate Development, MetricStream & Business Head ComplianceOnline

Mark has over 25 years of experience in enterprise software, corporate and business development, and mergers and acquisitions in various Silicon Valley technology companies. He played a key role in building valuable technology businesses in the US and globally, in several C-level roles. He was a co-founder at eMeter, a leading smart-grid company acquired by Siemens AG. He also held key operating executive and corporate and business development leadership roles at Serious Energy, Intematix, Scayl, and Law.com.

Most recently, Mark was SVP Business Development at RiverMeadow, a leading provider of SaaS solutions for migration of servers into the Cloud. Mark's experience spans a range of businesses, including Fortune 500 and Global 1000 customers in the Americas, EMEA, and APAC. He is also a named inventor on three patents.

Mark holds a Master's degree in Business from Stanford University's Graduate School of Business, a Juris Doctorate from the University of California, Hastings College of the Law, and a Bachelor's degree in Computer Science from University of the Pacific.

Kevin Fleming National Healthcare Managing Director, Newport Board Group

Kevin has over 30 years of senior executive experience in the Health Care, Financial Services, Technology and Professional Services Industries in roles including CEO, President, COO, Managing Director and Senior Partner.

  • Newport Board Group - Partner 2013 - Current
    • Managing Director of Nationwide Healthcare & Life Sciences Consulting Practice with 29 professionals, most former CEO's. Overall firm has nearly 100 partners nationwide.
    • ePAY Healthcare - Acting CEO and Board Member (2013 - Current)
      • Nationwide Healthcare IT SAAS Company with operations in 42 states serving over 650 Hospitals, Ambulatory Surgical Centers and other providers.
      • Comprehensive Patient Responsibility Financial Management Platform to maximize patient revenue collections and introduce innovative lending and other financing options.
      • Responsible for all primary aspects of the company.
    • Leads/Directs M&A Buy and Sell, IPO, Capital Raising and other events.
    • Serves as a Board member for US Community Behavioral Health, a nationwide provider in Behavioral Health and Traumatic Brain Injury Post-Acute Care Rehabilitation.
    • Performs strategic Board and CEO level consulting and advisory projects for clients.
  • Paradigm Outcomes - CEO 2006 - 2012
    • Nationwide Catastrophic Injury and Chronic Pain management full service and risk taking Healthcare Accountable Care Organization (ACO)
    • Served also in progressive capacities as Board Director, President, CFO & COO
    • Orchestrated a highly successful turn around and monetization of the company.
  • Electronic Data Systems - Managing Director 2003-2006
    • Executive Leader for a very large strategic business unit serving the healthcare and financial services industries. Clients included Blue Shield, McKesson, UCSF Medical, HSBC, Visa and Citigroup.
    • Achieved significant top line and bottom line growth while securing key new logo revenue clients.
  • Ernst & Young - Senior Partner 1980 - 2000
    • Coordinating Partner for major accounts including Healthnet, Foundation Health, Bank of America, Wells Fargo and others. One of the youngest partners in the firms history.
    • Chairman and executive leader of a very successful nationwide M&A and post merger integration practice
  • Professional Groups - Bay Area Alliance of CEO's, Financial Executives Institute (FEI), AICPA & California CPA Societies.
Patrick Rousche Co-Founder and Chief Scientific Officer, Hemotek Medical, Inc

Eduardo Cervantes President & CEO, Morf Media Inc

Eduardo Cervantes is President and CEO of Morf Media, a leading compliance training system vendor which is enabling the Millennial, and subsequent generations to effectively train on compliance. Previously, Eduardo led several successful exits through M&A in the technology industry domestically and in Europe. He started his career in M&A with Goldman Sachs where he worked major consumer and pharma transactions. Eduardo holds an MBA and an MS from the University of Texas at Austin.

Tom Loker Businessman | Author | Speaker, Startup Consultant and Advisor SYDK.ORG, Contributor to California Political Review

Tom has had an extensive history in healthcare. As an Angel Investor, Mentor and Advisor at Keiretsu Forum & Venture-Med and an established operations guy with serial successes with startups, transitional companies and turnaround situations, Tom has had a long career serving in the fields of science, technology and healthcare related industries. He is an active board member in both for-profit and not-for-profit companies. Tom has written numerous articles in the areas of healthcare, health tech, health policy, politics and the economy of healthcare. He is currently the principal author, along with a number of other contributors, of Health Reform 2.0: Beyond partisan divide lies pragmatic solutions – a working whitepaper focused on moving beyond the partisan rhetoric of the ACA (Obamacare) to a simple, efficient, effective, accessible and affordable healthcare system.

Tom has been involved with healthcare reform for many years, going back prior to President Obama's election. He was active during the debate, advising on how to effectively get services to the underserved. He was a strong advocate for using true patient centered systems to improve the quality of care and patient outcome and was pivotal in the insertion of the concept of coordination of care and benefits as a repeated tenant of the Affordable Care Act. Tom is one of the few people that has read almost every word of every piece of legislation that came out of the various committees, as well as the various versions of the final legislation.

Tom's understanding of the history of care in America helpes him get others to understand how we got to the non-system we have today, as well as how this system needs to fundamentally change in order to develop into the system we need for tomorrow. Tom's work on this whitepaper, mentioned above has been heralded as a fresh and valid approach to move beyond the ACA, or Obamacare, and get to a truly workable solution.

In the healthcare space, Tom has long maintained a passion for serving the underserved and has founded, supported and worked in various companies to serve the most fragile among us. He has developed a number of detailed approaches to solving the issues in the current, and evolving healthcare system. Because of his understanding and expertise in the business of healthcare, he has been invited to conduct multiple congressional briefings on healthcare reform in Congress, meeting with more than 100 congressional representatives.

Susan W. Neadle Sr. Director, Janssen Pharmaceuticals

Susan W. Neadle is a member of Janssen's Global Product Quality Leadership and is a Design Excellence Black Belt. Her accountabilities span from leading Janssen's Combination Product Center of Excellence to creating new quality frameworks for emerging platforms and technologies, Design-to-Value, criticality analysis and risk management, and Quality Engineering for Janssen's portfolio of products.

Over her extensive career, Susan has played integral leadership roles in the product and process development of over a dozen new products. She was awarded the Johnson Medal, Johnson & Johnson's highest honor for innovation excellence, for invention and development of a product platform central to J&J Vision Care's portfolio. This technology was also awarded the "SILMO Award" for Innovation, Technology & Creativity in Europe, and the "Good Design Award" in Asia.

Susan's experience includes enabling and applying advanced product and process analytics to drive proactive process capability and product quality. She is a core-team member of the J&J Convergent Technologies Network. She has been recognized for her contributions in CTQ Flow-Down, DTV and PLM Initiatives, to drive improved robustness in product quality through the end-to-end lifecycle management.

Susan earned an M.S. in Polymer Science & Engineering, and a B.S. in Biology/Chemistry, and Fellowships in the American Academy of Optometry and the British Contact Lens Association. Prior to joining J&J, she held R&D, quality, and commercialization positions at Unilever, Organon Teknika, and IBM. In these positions she worked in controlled release technology, biomedical diagnostics, and materials analysis.

In addition to Susan's professional experience, she holds numerous patents, has written a variety of papers, and has frequently presented on topics related to her contributions to, and areas of subject matter expertise in, the medical device and pharmaceutical industries.

Gunjan Sinha Executive Chairman, MetricStream

Gunjan Sinha is responsible for leading MetricStream's overall strategy and execution. Gunjan currently serves on the Board of Directors of several Silicon Valley companies, and was appointed in 2010 to the Board of the US-India Science and Technology Research Endowment Fund by the US State Department to promote entrepreneurship and innovation. Additionally, he is the Chairman of CFHI.org which brings transformative healthcare education to under-served communities.

Over the course of his career, Gunjan has spent over 20 years in various entrepreneurial, board, and executive positions building innovative businesses. He was the Co-Founder and President of WhoWhere? Inc., a leading Internet directory services company that was acquired by Lycos in 1998, as well as eGain, an online customer service company which he built from inception to post NASDAQ IPO.

Gunjan obtained his BS and MS degrees in Computer Science from the Indian Institute of Technology, New Delhi, and UC Santa Cruz, respectively. He also holds an MS in Industrial Engineering and Engineering Management from Stanford University. Gunjan has been featured as one of the 50 most successful immigrant entrepreneurs in the US by Silicon India.

Julia Rasooly Founder and CEO, PuraCath Medical Inc

Ms. Rasooly is the Founder and CEO/ President of PuraCath Medical -- a medical device startup in home dialysis and was spun out of Stanford University during her graduate school education in 2012. Ms. Rasooly has over twelve years of experience in R&D in medical device and biotech industries. She is focused on revolutionizing the dialysis industry and bringing her novel home dialysis technology to make dialysis at home safer and more affordable. Prior to being the Founder and CEO of PuraCath Medical, she was a researcher at the renowned Molecular Imaging Laboratory at Stanford University School of Medicine, where she worked on stem cell therapy and imaging projects. Julia has obtained a B.Sc. in Bioengineering from the University of California Berkeley, an M.S. in Bioengineering from Stanford University, an M.S. in Medicine from Stanford University, and a Certificate from the Summer Institute for Entrepreneurship from the Stanford Graduate School of Business (GSB). She took a "“leave-of-absence" from her PhD program in Bioengineering from Stanford University to grow PuraCath on a full-time basis. She has won multiple honors and awards, including the Howard Hughes Medical Institute Medical Scholar, the National Ford Foundation Pre-Doctoral Fellowship, the National Coca-Cola Scholarship, and multiple other governmental grants and awards for start-up ventures. She also is the co-founder and President of two non-profits focused on tech entrepreneurship as well as women entrepreneurs in healthcare.

Joe Franchetti FDA Regulatory Compliance Specialist, JAF Consulting Inc

As JAF Consulting, Incorporated's Managing Consultant, Joe Franchetti is an industry leader and teacher for 21 CFR Part 11, Annex 11, HIPAA, software validation, and computer system validation in regulated environments. For over 20 years, Joe has been involved with the development, purchase, installation, operation and maintenance of computerized systems used in all phases of drug development. In addition, Mr. Franchetti has over twenty five years of progressive experience in information technology and data management in the pharmaceutical and lie science industry.

He has extensive experience with all aspects of computer systems validation and compliance and is involved with the ACDM Clinical Research-CSV Working Party working on a chapter on GAP analysis, and has recently been involved with a chapter on Risk Assessment for the recently released DIA PEACH publication on Computerized Systems used in Clinical Trials and has also been involved with the GAMP Special interest Group on Laboratory Systems publication. Joe is currently the Training Chairperson for the Society of Quality Assurance's Computer Validation Initiative Committee.

Jon Speer Founder and VP of QA/RA, greenlight.guru

Jon is the Co-founder & VP of QA/RA at greenlight.guru, a software company that produces beautifully simple quality management software exclusively for medical device companies. He is also the founder of Creo Quality, a consultancy that specializes in assisting startup medical device companies with product development, quality systems, regulatory compliance & project management. Jon started his career in the medical device industry over 16 years ago as a product development engineer after receiving his BS in chemical engineering from Rose-Hulman Institute of Technology.

Rick Williams Partner, Newport Board Group New England Practice, Chairman of Point Care Technology, Board Member of Amorphex Therapeutics

As Chairman of the Board for an international medical device company,led successful strategic repositioning work in response to the evolving technology, market and financial environment. The repositioning involved a product transition from hardware to disposables.Lead funding initiatives with private and VC investors. Founded and led an award winning real estate development company. As Board Chair, led the transformation of a quasi-public state agency into a one stop center for small firms lacking access to conventional financing. Led large projects for public and private clients on the impact of regulation on major US industries. He as helped numerous companies and investors evaluate new business opportunities.

Board member of VC backed med tech company bringing slow release long term drug delivery product to market.

David Nettelton Industry Leader, Author, and Teacher for 21 CFR Part 11, Annex 11, HIPAA, Software Validation, and Computer System Validation

Computer System Validation's principal, David Nettleton is an industry leader, author, and teacher for 21 CFR Part 11, Annex 11, HIPAA, software validation, and computer system validation. He is involved with the development, purchase, installation, operation and maintenance of computerized systems used in FDA compliant applications.

He has completed more than 230 mission critical laboratory, clinical, and manufacturing software implementation projects. His most popular book is Risk Based Software Validation - Ten easy Steps, which provides fill-in-the-blank templates for completing a COTS software validation project.

Rohit Bedi Senior Vice President & Executive Leadership, MetricStream

As the SVP of Partnerships, Rohit is responsible for leading global partnerships by enabling the influence, distribution and delivery capabilities of our partners.
In a career that spans the full lifecycle of enterprise software, Rohit has been involved with building dominant software brands and successful companies in leadership roles. Most recently, Rohit led large company partnerships and strategic business in enterprise software at Cognizant. Prior to that, he was part of the executive team at Cymbal where he managed worldwide sales, marketing and partnerships leading to a successful acquisition. In the growing days of Seibel, he was responsible for an entire product line at Siebel Systems including expanding the partner network which played a big role in Siebel's distribution and delivery channel expansion. He was also in Product marketing roles at PeopleSoft.

Rohit is very passionate about coaching young juniors and has advised growing entrepreneurial firms in software and services. He has also helped institutions that support talented underprivileged children in golf. Rohit received his MBA from Harvard University, M.S. from the University of Alabama, and B.E. from Delhi College of Engineering, all with honors.

Vesna Janic Director of Quality/Regulatory, StarFish Medical and ViVitro Labs Inc.

Vesna Janic is a Director of Quality/Regulatory Department at StarFish Medical and ViVitro Labs. Her expertise is in regulatory compliance and conformance with standards, such as: cGMP, GLP, GCP, QSR, ISO 13485 and ISO 17025. Vesna is certified by the SQA as a Registered QA Professional in GLP, has Lead ISO 13485 Auditor certificate and holds a Bachelor of Science degree in Biology.

Vesna has 18 years of experience as part of Senior Management team and 10 years as SCC GLP inspector (volunteer position), and 8 years as QA/RA Director in medical devices field.

Prior to joining StarFish and Vivitro, Vesna worked for 6 years for CANTEST, life science company providing QA support to pharmaceutical division conducting GCP, GLP and GMP testing; 10 years with BC Research: in R&D – 6 years, followed by 4 years as a Quality Manager supporting GLP, GMP and ISO 17025 testing in chemistry and ecotoxicology departments.

Matt Matuszewski Director Operations, Johnson and Johnson

Lifei Liu, PhD, RAC Associate Director, Regulatory Affairs at Abbott

Michael A Swit Principal, Law Offices of Michael A. Swit

Michael A. Swit focuses on solving the legal challenges confronted by the pharmaceutical, medical device, and other life sciences industries in tackling the myriad of legal mandates enforced by the U.S. Food & Drug Administration. Mr. Swit has extensive experience counseling life sciences firms on the demands of compliance with FDA's statutory and regulatory requirements to develop and market safe and effective drugs, biologics, medical devices, IVDs and other products. He also has advised regulated firms on a wide range of FDA regulatory matters, including drug and device approvals and marketing/promotional claims, dietary supplement health claims and regulatory issues in corporate acquisitions. His experience includes FDA development strategies, compliance and enforcement initiatives, recalls and crisis management, submissions and related traditional FDA regulatory activities, labeling and advertising, and clinical research efforts.

Mr. Swit has been addressing critical FDA legal and regulatory issues since 1984. Before joining Duane Morris LLP, Mr. Swit served for seven years as vice president at a preeminent scientific and FDA regulatory consulting firm, where he developed and ensured execution of a broad array of regulatory and other services to clients, both directly and through outside counsel.

Michael Weickert Strategic & Entrepreneurial Executive, Trail-blazing Leadership in Biotech, Medical Device & Pharmaceutical Business

Register by phone or need assistance? Call +1-888-717-2436 Register Now Download Brochure
Register Online

Register Online

Get the Invitation
Pre-Register yourself and get the official Invite when venue and dates are announced for this seminar.
Call here to register +1-1-888-771-6965 or email at editor@grcseminars.com

Group Registrations

Send Your Team for Maximum Benefit Get your team up to speed!

Significant tuition discounts are available for teams of two or more from the same company. You must register at the same time and provide a single payment to take advantage of the discount.

  • 2 Attendees
  • 3 to 6 Attendees
  • 7 to 10 Attendees
  • 10+ Attendees
  • -
  • -
  • -
  • -
  • Get 10% off
  • Get 20% off
  • Get 25% off
  • Get 30% off
Call Toll Free +1-1-888-771-6965 if you have any queries.

Register by Wire Transfer

If you wish to pay by wire transfer: Please call us at
Toll Free +1-1-888-771-6965

Download Registration Form

Yes, I want to attend "4th Annual Medical Device Summit 2018"
Click here to Download Registration Form
If you are paying by check:
Checks should be payable to MetricStream Inc. (our parent company). and mailed to:
2479 East Bayshore Road, Suite 260
Palo Alto, CA 94303

Terms & Conditions to register for the Seminar/Conference/Event

Your Registration for the seminar is subject to following terms and conditions. If you need any clarification before registering for this seminar please call us @ +1-888-771-6965 or email us @ editor@grcseminars.com


Payment is required before 2 days of the date of the conference. We accept American Express, Visa and MasterCard. Make checks payable to MetricStream Inc. ( our parent company)

Cancellations and Substitutions:

Written cancellations through fax or email (from the person who has registered for this conference) received at least 10 calendar days prior to the start date of the event will receive a refund — less a $300 administration fee. No cancellations will be accepted — nor refunds issued — within 10 calendar days from the start date of the event.

On request by email or fax (before the seminar) a credit for the amount paid minus administration fees ($300) will be transferred to any future GRC Seminars event and a credit note will be issued.

Substitutions may be made at any time. No-shows will be charged the full amount.

We discourage onsite registrations, however if you wish to register onsite payment to happen through credit card immediately or check to be submitted onsite. Conference material will be given on the spot if it is available after distributing to other attendees. In case it is not available we will send the material after the conference is over.

In the event GRC Seminars cancels the seminar, GRC Seminars is not responsible for any airfare, hotel, other costs or losses incurred by registrants. Some topics and speakers may be subject to change without notice.

Attendance confirmation and Documents to carry to the seminar venue:

After we receive the payment from the registered attendee an electronic event pass will be sent to the email address associated with the registrant before 5 working days from the seminar date. Please bring the pass to the venue of the event.

Conference photograph / video:

By registering and attending GRC Seminars conference you agree to have your photographs or videos taken at the conference venue and you do not have any objections to use these photos and videos by GRC Seminars for marketing, archiving or any other conference related activities. You agree to release GRC Seminars for any kind of claims arising out of copyright or privacy violations.


What past attendees say:

I think the summit was very well run and organized. It provided an excellent environment that was conducive to relaxed and meaningful interactions between FDA, industry, and even foreign medical device regulatory agencies.
- Medical Officer, Center for Devices and Radiological Health,U.S. Food and Drug Administration (FDA)

This event was very focused on FDA regulatory training, standards and guidance. This was the main reason that I attended in this event and the event delivered all with high quality.
- Research and Development Program Manager IV,Abbott

The FDA speakers really added a lot of value. There were many experienced industry speakers & I learned a lot from them.
- CEO,Springborne Life Sciences

The summit was great success on my opinion, very knowledgeable speakers and interesting topics. I extended my network of contacts that beneficiary for our company. Thank you for giving this great opportunity and hoping to attend another one next year.
- Quality Assurance Manager,BCSI SAFE Sens

Very interesting & informative sessions.
- Director, Device Manufacturing, Vital Therapies

It was a pleasure to work with GRC Seminars as the conference organizers. Communication was timely and complete. Support in preparation of the program was excellent and the level of organization was high - as a speaker, all I needed to do was prepare the talk and show up. As a participant listening to other presentations, the content was generally very good and I came away learning more than I contributed.
- President & CEO, Directional Healthcare Advisors, LLC

I thoroughly enjoyed the summit because it gathered speakers of various background (even FDA and ex-FDA officials) to discuss a wide range of topics related to device industry. I learned a great deal of software security and its impact on devices. This is an area that is new and exciting.
- Corporate Regulatory Compliance Manager, Quality Packaging Specialists International

Overall it was good experience. It was great to hear directly from the FDA's perspective. Most of the sessions were thorough and very informative.
- Production Manager, Centurion Medical Products

Excellent presentations with lot of examples. Well Done!
- Senior Director,Sanofi

I thoroughly enjoyed the summit. I hope the next summit will also be held in Boston.
- Medical Device Expert,Sanofi

With notable speaker, a broad range of topics and great networking potential, this conference was an amazingly good investment of time.
- Principal Consultant,Shoebar Associates

There was a very good presence of the FDA, who provided brief regulatory insights.
- President and Chief Scientist,HirLan, Inc.

Excellent mix of topics with great presentations, worth every penny and time we spent there.

Excellent speakers, diverse experience and background.
- Senior Manager,Global Security Risk Management, Edwards Lifesciences

A great learning opportunity. Relevant topics with approachable and knowledgeable presenters from industry and regulatory perspective.
- Senior Director, Head of Software Management, Philips

Excellent speakers. All topics were valuable. Excellent participant involvement across the whole group.
- QA-RA Director, Easy Sense

Very informative, learned a lot, got connected with speakers who will help us in designing the product.
- Manager, Grifols

The event was extremely well organized. All topics were useful to me.
- Product Line Manager, NxP

Lot of useful information and I have learnt a lot. Supplying slide decks to the participants was a master stroke.
- Manager, Draeger Medical Systems Inc.

Excellent speakers. Topics were very helpful.
- Quality System Tech, Milliken Healthcare Products

Excellent speakers. The event was well organized.
- Assistant Director Quality, AbbVie

Great presentations and subjects covered.
- Director, Regulation Combination Devices, EMD Serono

The summit was well organized.
- Medical Device Expert, Sanofi

FDA speakers were excellent and topics covered were beneficial.
- Quality Manager, Fisher & Paykel Healthcare

Sponsors, Exhibitors and Media Partners:

We are pleased to offer several exhibitor, sponsorship and media partnership options designed to maximize your company's exposure and networking opportunities before, during and after the event.

Benefits of becoming a Sponsor/Exhibitor/Media Partner:

  • Logo on website, marketing email, branding materials & the registration booth
  • Exhibit Space
  • Free event pass
  • Speaking opportunity
  • Social media campaign

For more details and other sponsorship options at this Summit, please contact Summit Manager: customercare@grcseminars.com or call: +1-888-771-6965

Media Partners

Past Sponsors, Exhibitors and Media Partners:

Medical Device Summit Partners & Sponsors

Local Attractions

Think Escape Party Bus
Board a luxurious Think Escape party bus or limo and be whisked away to San Francisco's hottest nightclubs where VIP treatment brings all party bus guests to the front of the line. Planning the perfect night on the town is easy with Think Escape's fleet of luxury buses and extended vehicles, each with different amenities for socializing and transport.

Alcatraz Lunch Cruise
The Alcatraz Lunch Cruise is a luxurious way to get to see some of San Francisco’s favorite sights. A gourmet lunch buffet features options like asiago Caesar salad, bay shrimp salad, roasted chicken, garlic-herb roasted new potatoes and more. While guests enjoy lunch, they can take in views of San Francisco Bay’s flora and fauna, Angel Island and Alcatraz, and a live narration explores the history of Alcatraz. Please note that this tour doesn’t stop on Alcatraz Island.

Luxury Catamaran Sailing Cruise
A relaxing way to explore the San Francisco Bay is with the Luxury Catamaran Sailing Cruise. A drink bar and snacks are available for travelers’ enjoyment as they travel under the Golden Gate Bridge, around Alcatraz Island and even past a colony of sea lions. This is a peaceful San Francisco cruise option for families, and children under 5 ride for free.

City Kayak
City Kayak, located on San Francisco's Embarcadero close to the San Francisco Giant's ATT Park, offers a great way to experience San Francisco from Bay level, a point of view and a unique experience you'll not soon forget.

Think Escape Casino Tour San Francisco Bay Area
San Franciscans may be familiar with Think Escape's party buses that shuttle the late-night crowds to and from various city nightclubs, but the Cache Creek Casino Escape is a little-known gem among Bay Area destinations. With personal charter service on the luxurious Fantasy Limo Bus to Cache Creek Casino and Resort, the Cache Creek Casino Escape tour is a smart choice for San Franciscans looking for a little gaming fun or planning a large group activity